The new 3-year agreement deepens a long-standing relationship between the two companies and provides Charles River with new opportunities to support future growth. LONDON, Titian Software and Charles River Laboratories have entered into a new 3-year partnership agreement, expanding Charles River’s sample management capabilities. Titian’s Mosaic sample management software is already well-established within Charles River’s […]

Cambridge, UK – SPT Labtech, a global leader in the design, development and manufacture of automated instrumentation and consumables for life science applications, announces that its firefly liquid handling platform has been selected by Colossal Biosciences to enhance its Next Generation Sequencing (NGS) capabilities. firefly will be installed in the headquarters in Dallas, Texas, to automate NGS library preparation, […]

Cambridge, United Kingdom – Congenica, a UK-based digital health company specialising in innovative software and solutions for genomic data analysis and interpretation, is pleased to announce its selection for the third phase of a contract to develop standardised Next-Generation Sequencing (NGS) workflows in oncology. The European Union Horizon 2020 co-funded project, ‘INtegrated and STANDardized NGS workflows […]

The Hospital will enhance its testing and research of blood cancers with the SOPHiA DDM™ Platform  Boston, MA and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Instituto Mário Penna is live on the SOPHiA DDM™ Platform. Located in Belo Horizonte, Brazil, […]

The SOPHiA DDM™ Platform will help broaden the hospital’s cancer testing and diagnostic capabilities  Boston, MA and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that Klinikum Klagenfurt am Wörthersee, the third largest hospital in Austria, is live on the SOPHiA DDM™ Platform. The hospital will use […]

SAN DIEGO — Element Biosciences, Inc., developer of pioneering technologies to empower science, today announced record growth in installations of its AVITI™ System ahead of its participation in upcoming investor conferences. Element has now received more than 200 cumulative orders of AVITI – the sequencer that provides the highest quality sequencing on a benchtop for […]

FlexFactory platform for oligonucleotides, an integrated solution to boost efficiency and speed of pharmaceutical manufacturing to meet market demand Ribobay Pharma, a leading Chinese biopharmaceutical contract research, development, and manufacturing organization (CRDMO) and a spin-off company of General Biol (Anhui) Co., Ltd, will provide cGMP-level oligonucleotide (oligo) CRDMO services to the world using Cytiva’s first […]

Hamilton BiOS Franklin, Mass, USA / Domat/Ems, GR, Switzerland – Hamilton Storage Technologies, Inc., announced today that four high-capacity Hamilton BiOS® automated storage systems will be installed in UK Biobank’s new Manchester Science Park headquarters. UK Biobank is the world’s most comprehensive source of health data available for research, housing a vast and continuously growing dataset of biological, health, […]

MENLO PARK, Calif. – Deepcell, a pioneer in artificial intelligence (AI)-powered single cell analysis to fuel deep biological discoveries, today announced the first commercial placement of the REM-I platform at Erasmus Medical Center in Rotterdam. This commercial milestone follows placements of pre-commercial instruments laboratories in Europe and the U.S. for Beta testing. In addition, the company announced plans […]

11 installs successfully completed Novel platform automates and accelerates protein production, enabling scale-up to mg amount in less than 48 hours List of institutes includes, University College London, University of Cambridge, University of Southampton, University of Manchester, The Flanders Institute for Biotechnology (VIB) in Belgium, and the CRUK Cambridge Institute Cambridge, UK: Nuclera, the biotechnology company […]